ANAB: AnaptysBio, Inc. Stock

by  •  • Comments Off on ANAB: AnaptysBio, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 502.94
Enterprise Value ($M) 733.28
Book Value ($M) 70.87
Book Value / Share 2.31
Price / Book 7.10
NCAV ($M) 18.91
NCAV / Share 0.62
Price / NCAV 26.60

Profitability (mra)
Return on Invested Capital (ROIC) -0.33
Return on Assets (ROA) -0.32
Return on Equity (ROE) -1.65

Liquidity (mrq)
Quick Ratio 9.51
Current Ratio 9.51

Balance Sheet (mrq) ($M)
Current Assets 431.88
Assets 483.83
Liabilities 412.97
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 91.28
Operating Income -114.95
Net Income -145.23
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -135.34
Cash from Investing 95.40
Cash from Financing 127.05

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
3 days ago 13G First Light Asset Management, LLC 15.17
02-18 13G Point72 Asset Management, L.P. 5.60 114.49
02-14 13G/A Frazier Life Sciences Public Fund, L.P. 5.40 -13.66
02-14 13G/A Fairmount Funds Management LLC 0.00
02-05 13G/A BlackRock, Inc. 8.40 41.60
11-14 13G/A Deep Track Capital, LP 0.00 -100.00
11-14 13G/A Tang Capital Management Llc 4.40
08-16 13D/A EcoR1 Capital, LLC 25.80 3.65
07-10 13G Fmr Llc 10.51 1,515.07
2024-02-14 13G/A Tang Capital Partners Lp 7.30 -25.80
2024-02-13 13G/A Vanguard Group Inc 5.19 -22.33

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-05 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-05 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-11 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-07 174,413 510,332 34.18
2025-03-06 109,700 451,904 24.28
2025-03-05 133,677 535,022 24.99
2025-03-04 187,990 672,134 27.97

(click for more detail)

Similar Companies
AMLX – Amylyx Pharmaceuticals, Inc. AMPH – Amphastar Pharmaceuticals, Inc.
AMRX – Amneal Pharmaceuticals, Inc. ANNX – Annexon, Inc.
APLS – Apellis Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io